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Introduction
Diagnostic coronary angiography was first reported by 
Sones and Shirey (1) in 1959; it is the most used procedure to 
assess the severity of coronary artery disease (CAD). In 1974, 
Gould et al. (2) studied the association between coronary ste-
nosis and functional reduction of maximal coronary flow was 
studied in animals and observed a relation between coronary 
stenosis percentage and coronary flow. The maximal flow pro-
gressively decreases from 50% to 80% stenosis with a resting 
flow decrease above 80% stenosis (2). Since general assump-
tion has been made which define a significant coronary steno-
sis as ≥70% luminal diameter narrowing or ≥50% of a left main, 
by visual assessment of an epicardial stenosis measured in the 
“worst view” angiographic projection (3). As such, coronary 
angiography formed the basis for the revascularization clinical 
decision-making of this prevalent disease. It is noteworthy that 
White et al. (4) performed a study similar to Gould et al. (2) 10 
years later in patients undergoing coronary artery bypass graft 
and did not observe a similar relation between coronary stenosis 
and flow. Several reasons were given to explain the difference 
in results between experimentation in animals by Gould et al. (2) 
and observation in patients by White et al. (4). The animal ex-
perimentation was performed with a control setting in healthy 
animals and surgically controlled diameter stenosis according to 
the experimental protocol, whereas the patients had risk factors, 
comorbidities, microvascular impairment, and tissue aging. Cor-
onary stenosis could be diffuse along the coronary artery with 
vessel remodeling and could interest different territories sup-
plied by variable amount of myocardial mass with heterogenic 
collaterals network. All these parameters contribute to a unique 
flow distribution, which affects the balance between myocardial 
supply and demand of oxygen in stable patients and therefore im-
Myocardial ischemia is a leading cause of death worldwide, and it corresponds to the imbalance between blood supply and myocardial demand. 
Epicardial coronary artery disease (CAD) is detected on the basis of coronary angiogram, whereas invasive detection of myocardial ischemia in-
duced by coronary stenosis is commonly based on fractional flow reserve (FFR). The use of FFR for revascularization decision-making demonstrated 
clinical benefit and cost-effectiveness compared with that of angiographic indices. Discrepancies between anatomical metrics and physiological 
assessment of CAD are frequent, which lead to change in revascularization decision from angiography compared to functional evaluation of CAD. 
Despite several clinical studies and guidelines recommending with high level of evidence demonstrating that FFR should be adopted in stable CAD, 
revascularization decision-making is still based on coronary angiogram in current practice. Because of the unique coronary anatomy, coronary ste-
nosis characteristics, risk factors profile, and microcirculation quality, the unique evaluation based on epicardial coronary stenosis threshold failed 
to be a landmark of ischemia compared with FFR. Furthermore, coronary angiogram can detect only epicardial vessels, which represent only 10% 
of the entire coronary vasculature; therefore, microcirculation is not seen and is poorly assessed in clinical practice. Thus, the role of microcircula-
tion is of importance in myocardial ischemia and might impact these discrepancies between angiography and FFR evaluation of CAD. In this review, 
we aimed to describe the poor correlation between anatomical evaluation compared with physiological evaluation to detect myocardial ischemia 
induced by coronary stenosis as well as the clinical implications of this visual–functional mismatch. (Anatol J Cardiol 2018; 20: 182-9)
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pact differently the coronary flow with similar apparent coronary 
stenosis assess by angiography (5). Fractional flow reserve (FFR) 
became the gold standard invasive test to detect myocardial 
ischemia induced by a coronary stenosis. FFR is recommended 
(IA) in stable coronary artery stenosis of more than 50% when 
evidence of ischemia is not available (6). Despite the evidence 
provided by several randomized trials and multiple observational 
studies (7-10), the adoption of FFR has been slow in many areas. 
The mismatch between anatomical and functional evaluation of 
coronary stenosis has been extensively described and showed 
frequent redistribution in revascularization indication (Fig. 1) (11). 
In this general paradox, the percentage of diameter stenosis (DS) 
does not reliably relate to FFR (12, 13); therefore, revasculariza-
tion procedures to improve coronary blood flow based on coro-
nary angiogram do not reduce coronary events compared with 
optimal medical therapy in randomized trials (14). In contrast to 
these trials, revascularization guided by FFR had significantly 
fewer follow-up coronary events than percutaneous coronary 
intervention (PCI) based on angiographic DS (15, 16). The aim of 
the current review is to describe the possible reasons and clini-
cal implications of mismatch between anatomical indices and 
FFR values.
Fractional flow reserve
FFR has been defined as the ratio of maximal myocardial 
blood flow in the presence of stenosis to the normal maximal 
myocardial blood flow (i.e., in the absence of stenosis) (17). It is 
derived from proximal and distal coronary pressures measured 
during hyperemic conditions. FFR quantifies the extent to which 
an epicardial obstruction limits maximal blood flow and predicts 
the potential benefit of medical therapy and revascularization.
Calculations
FFR expresses the ratio of maximal myocardial flow in the 
presence of stenosis (Qs) to the normal hypothetical maximal 
myocardial flow of the same territory without stenosis (Qn): 
FFR=Qs/Qn. Based on Ohm’s law, the flow can be expressed as 
the ratio of the driving pressure to the resistance (R) of the sys-
tem, which is the coronary circulation in this case. The driving 
pressure is the aortic (Pa for Qn and Pd for Qs) and venous pres-
sure gradient (Pv). Accordingly, the formula can be substituted 
as follows: FFR=[(Pd –Pa)/R]/[(Pd –Pa)/R]. The measurements 
are obtained under maximal relaxation of both the macrovascu-
lar and microvascular compartments; therefore, the resistance 
of the system is minimal and cancels in the simplified equation: 
FFR= (Pd –Pv)/(Pa –Pv). In the absence of congestive heart fail-
ure, the venous pressure is negligible compared with the aortic 
or coronary pressure (18). A simpler formula was derived and 
used in the trials and clinical practice: FFR=Pd/Pa at maximal hy-
peremia. Practically, FFR is calculated as the ratio of two mean 
pressure measurements (17), the distal coronary pressure Pd 
divided by the proximal coronary pressure or aortic pressure Pa 
under maximal hyperemic condition. The accuracy and physi-
ologic meaning of FFR depend on the induction of maximal hyper-
emia. Only maximal hyperemia abolishes all mechanisms respon-
sible for the control of resting blood flow to achieve a Pd/Pa ratio 
Figure 1. Example of a 67-year-old patient with positive stress magnetic 
resonance imaging (MRI) in an anterolateral wall perfusion defect 
(lower left panel), showing angiographically significant stenosis of 
circumflex and marginal coronary arteries and nonsignificant left artery 
descending (LAD) coronary artery (upper left panel). FFR was significant 
for ischemia in LAD and nonsignificant in the circumflex and marginal 
coronary arteries in agreement to stress MRI imaging (right panel)
Table 1. Studies comparing indices obtained by angiography or intracoronary imaging compared with FFR presented in Figure 4
Study Name Year Journal Sensitivity Specificity Number of  
      vessels
VE Danad et al. 2016 Eur Heart J 2017 Apr 1; 38 (13): 991-998 71 66 954
QCA Toth et al. 2014 Eur Heart J 35 (40): 2831-2838 61 67 4086
QCALM Toth et al. 2014 Eur Heart J, 35 (40), 2831-2838 35 76 152
IVUS Nascimento et al. 2014 Catheter Cardiovasc Interv 84: 377-385 66 80 1953
IVUSLM Nascimento et al. 2014 Catheter Cardiovasc Interv 84: 377-385 90 90 110
OCT Pawlowski et al. 2013 Int J Cardiovasc Imaging 29 (8): 1685-1691 75 90 71
3D QCA Tu et al. 2014 JACC Cardiovasc Interv 7 (7): 768-777 83 56 77
QFR Xu et al. 2017 J Am Coll Cardiol 70 (25): 3077-3087 92 93 332
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that equals the corresponding flow ratio governed by a linear rela-
tionship between perfusion pressure and hyperemic flow (19, 20).
Practical aspects
During the coronary angiography procedure, intracoronary 
nitrates are administered prior to the FFR measurements. The 
guiding catheter measures Pa. Pd is measured by a dedicated 
intracoronary pressure guidewire placed downstream the cor-
onary stenosis to be investigated. Hyperemic steady state can 
be induced by drugs such as intravenous (IV) adenosine (at 140 
mcg/kg/min), intracoronary (IC) adenosine (100 mcg for the right 
coronary and 200 mcg for the left coronary) (21). The FFR value 
is defined as the Pd/Pa value obtained during maximal steady 
state hyperemia (Fig. 1). FFR has a well-defined cutoff value for 
the probability of presence or absence of inducible ischemia at 
0.80 or below. It is extremely unlikely to observe definitive myo-
cardial ischemia with FFR > 0.80. Therefore, an FFR value of 0.80 
is a widely accepted and largely confirmed threshold to guide 
clinical decision-making (15, 16, 22, 23).
Clinical outcome data
Several randomized clinical trials and meta-analyses have con-
firmed the clinical value of FFR-based decision-making. When FFR 
is >0.80, the clinical outcome of the patient is not improved by re-
vascularization compared with the currently available best of medi-
cal care. This has been shown for all kinds of lesions, including left 
main stenosis, and different patient subsets (7-10, 15, 16, 24-30). In 
patients with multivessel disease, the application of FFR has led to 
the concept of functionally complete revascularization (26) as op-
posed to the prevailing practice of anatomically complete revascu-
larization (31). In contrast, when FFR is ≤0.80, FAME 2 has shown 
in patients with CAD undergoing elective PCI that outcomes are 
improved by drug-eluting stent implantation compared with medi-
cal therapy only in terms of urgent revascularization and symptoms 
and seems to improve death and MI at 5 years (16, 22, 32).
Those robust clinical outcome data established that FFR 
should be used for bidirectional reclassification of angiographi-
cally visible stenoses. When applied ad hoc during diagnostic 
angiography, the use of FFR transforms the invasive procedure in 
the catheterization laboratory into a “one-stop shop” that allows 
both morphological and functional evaluation of CAD.
Visual estimation evaluation
Visual estimation (VE) remains the easiest way to evaluate 
CAD. It requires prior intracoronary nitrate administration, op-
timal contrast injection into coronary arteries, and several pro-
jections. The eyeballing of coronary stenosis corresponds to DS 
seen in the “worst view.” This evaluation had large variability, 
which could not be a reliable and standard evaluation of CAD.
Visual estimation and fractional flow reserve
VE has been compared with FFR in a meta-analysis, wherein 
the sensitivity was 71% and the specificity was 66% (33). Simi-
larly, reclassification rate was studied in a French multicentric 
registry comparing a priori clinical decision based on VE com-
pared with that on FFR in 1028 patients (11). The reclassification 
rate was 43%. At one-year follow-up, the FFR strategy demon-
strated safety in terms of symptoms and clinical outcome. In-
terestingly, FFR induces high reclassification rate with small 
variation in overall therapeutics rates: The medical therapy and 
CABG rates increased of 3% in each group while reduction of PCI 
rate was only 6%. Moreover, these results were consistent with 
other studies comparing VE and FFR such as Ripcord study and 
CVIT DEFER registry (34, 35). Nakamura et al. (35) showed that 
the independent predictors for mismatch between VE and FFR 
<0.8 were previous PCI, one-vessel disease, non-left artery de-
scending (LAD) location, nondiffuse lesion, nonostial lesion, and 
nontandem lesion. Conversely, mismatch between VE and FFR 
>0.80 was independently associated with multivessel disease, 
LAD location, and diffuse lesion (35). FFR-based revasculariza-
tion strategy is safe at one year in daily clinical practice (36).
Quantitative coronary angiography
Quantitative coronary angiography (QCA) has been proposed 
to reduce variability and increase accuracy of CAD evaluation. 
Similar to VE, it requires nitrate administration and optimal coro-
nary opacification with contrast medium. The severity of the ob-
structive lesions is derived from the automatically detected con-
tours of the stenosis compared with the reference “healthy part” 
of the vessel during diastole phase to obtain DS. A metric land-
mark such as catheter or pixel size is needed to provide absolute 
values of the minimum lumen diameter, reference diameter, and 
lesion length (37).
Quantitative coronary angiography and fractional flow 
reserve
Toth et al. (12) compared 4000 coronary stenoses to FFR in a 
single center and observed a high rate of discordance between 
QCA and FFR. Approximately one-third of the population shows 
discordance between angiogram and FFR with a sensitivity of 
61% and a specificity of 67%. Left main (LM) stenoses are espe-
cially underestimated by the 50% DS angiographic cutoff com-
pared with FFR with a sensitivity of 35% and a specificity of 76%.
Discrepancies between visual estimation and QCA
Several studies have compared VE and QCA of CAD to sum-
marize that QCA underestimates mild lesions and VE overesti-
mates tight lesions (13). VE had higher variability than QCA. An 
international survey on interventional strategy aimed to present 
coronary angiogram without clinical context and showed ex-
treme variability of VE evaluation between 459 interventional car-
diologists (38). However, a sub-study of PROMISE trials compar-
ing VE and QCA evaluation to the clinical outcome in 929 patients 
observed that one-year unadjusted Kaplan-Meier event rates 
were highest (5.1%) when QCA and VE agreed for significant 
CAD, lowest (0.9%) when the 2 agreed for nonsignificant CAD, 
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and intermediate (3.1%) for patients who had significant CAD per 
VE but not per QCA. This study suggests that cardiologists inte-
grated clinical information into routine VE (39).
Visual estimation, quantitative coronary angiography, and 
fractional flow reserve
Similarly to the sub-study of PROMISE trial, a study compar-
ing VE and QCA to FFR in 1104 patients and 1382 stenoses showed 
a better diagnosis accuracy between VE and FFR than between 
QCA and FFR (13). Indeed, interrogating the patient, consulting 
the medical report, and performing other tests at rest might af-
fect the interventional cardiologists about clinical ischemia rel-
evance and therefore the VE assessment of CAD might be better 
correlated to invasive ischemic test. Of note, this study showed 
that compared with FFR, the false-negative rate of VE and QCA 
were three times higher in mild DS (<70%) than in tight DS (70%). 
This indicates that the general assumption that adopting FFR will 
dramatically reduce the number of revascularizations in centers 
is unsafe since mainly false-negative VE and QCA (DS <70%) have 
FFR <0.80. These lesions are generally not interrogated with FFR 
since they appear angiographically non significant. Therefore, 
based on these studies’ results, systematic FFR interrogation of 
a large range of diameter stenoses from 30% to 90% may lead to 
a high reclassification rate with a low reduction of revasculariza-
tion and safety in terms of clinical outcome and symptoms (Fig. 
2) (11, 13).
Intracoronary imaging and three-dimensional quantitative 
coronary angiography
The general limitation of VE and QCA is to found the “worse 
view” to assess DS for the following reasons. First, coronary 
arteries can overlap and have vessel foreshortening between 
different views. Second, coronary stenosis is predominantly ec-
centric; therefore, the diameter stenosis derived from the “worst 
view” might overestimate the severity of DS (40). Third, lesion 
length and vessel remodeling might affect focal lesion evalua-
tion. Thus, the principle to evaluate DS in three dimensions was 
proposed to assess coronary stenosis based on intracoronary 
imaging such as intravascular ultrasound (IVUS) and optical co-
herence tomography (OCT) or three dimensional (3D) QCA to ob-
tain a stenosis area.
Intracoronary imaging
Because of their higher spatial resolution, imaging of the vas-
cular wall layers and 3D reconstruction IVUS and OCT are superior 
to angiography in determining lesion severity. DS assessed by VE 
or QCA can be obtained in a cross-sectional area to determine the 
minimum lumen area (MLA) associated with the lesion length to 
obtain 3D evaluation of the studied coronary segment (Fig. 3). To 
date, no prospective randomized studies have demonstrated im-
provement in clinical outcomes using intravascular imaging. While 
these techniques provide important informations such as coronary 
plaque structure, volume, and stability. Intracoronary imaging de-
vices have significant cost and a lack of clinical evidence to im-
prove patient outcome such as mortality, myocardial infarction, 
stent thrombosis, or restenosis rates in current practice.
Intravascular ultrasound and fractional flow reserve
IVUS is an intravascular imaging modality that provides high-
resolution cross-sectional measurements of the lumen and ves-
sel areas (41). IVUS quantification of a stenosis has fewer ana-
tomic limitations than angiography. IVUS accurately measures 
MLA, which is more accurate than luminal DS assessed by QCA. 
Figure 2. VE and QCA values compared with FFR. Agreement between 
green true positive in the left upper panel and true negative in the right 
lower panel. Discordance between red false-positive in the right upper 
panel and false-negative in the left lower panel (13)
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Figure 3. Circumferential OCT imaging of coronary stenosis (a) with 
a diameter stenosis in an automated lumen profile (g). b, c, d, e, and 
F showed 2D longitudinal reconstruction with VE of DS according to 
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The main limitation is to ensure coaxial position. Although IVUS 
is an excellent method to determine plaque volume, its precise 
role in clinical decision-making has not been defined. Kang et al. 
(42) found a good correlation between IVUS and FFR for MLA <4.8 
mm2 with a sensitivity of 89% and a specificity of 83% in interme-
diate LM lesions. A meta-analysis compared MLA assessed with 
IVUS and FFR values showed for a weighted overall mean MLA 
cutoff of 2.61 mm2 in non-LM trials and 5.35 mm2 in LM trials with 
a limited accuracy with 20% reclassification. The sensitivity was 
79% and the specificity was 65% in non-LM trials, whereas the 
sensitivity and specificity were 90% in LM trials (43).
Optical coherence tomography and fractional flow reserve
OCT is an intravascular imaging based on near-infrared light 
with better resolution than IVUS, but less power of penetration. 
OCT imaging needs optimal and prolonged coronary opacifica-
tion with contrast medium to obtain good imaging quality. There-
fore, the main limitations of this technique are the need for extra 
contrast medium to perform OCT imaging and ostial segment of 
coronary arteries, particularly LM. OCT MLA and FFR correlations 
were evaluated in 48 patients and 71 intermediate coronary ste-
noses. An OCT MLA of 2.05 mm2 cutoff had a sensitivity of 75% and 
a specificity of 90% (44).
Intravascular ultrasound+optical coherence tomography 
and fractional flow reserve
A study aimed to evaluate the diagnosis accuracy of IVUS and 
OCT to predict FFR <0.75 in 186 patients and 203 non-LM steno-
ses. This study showed a moderate diagnostic performance of 
both IVUS with a sensitivity of 72% and a specificity of 47% as-
sociated with an optimal cutoff value of 2.57 mm2 and OCT with 
a sensitivity of 69% and a specificity of 69% associated with an 
optimal cutoff value of 1.39 mm2 (45). Comparison of the results 
showed better accuracy of OCT than of IVUS to predict signifi-
cant FFR values. Furthermore, using OCT, a multivariate analysis 
showed that older age, non-left anterior descending artery, and 
smaller angiographic reference diameter were independent pre-
dictors of false-positive results, whereas younger age and low 
left ventricular ejection fraction were independent predictors of 
false-negative results. These results highlight the importance of 
the impact of myocardial mass and microvascular compartment 
with CAD to induce myocardial ischemia.
Since OCT, like IVUS, evaluates anatomic dimensions rather 
than functional significance, its use in assessing coronary ste-
nosis hemodynamic impact will probably be limited. As a result, 
these imaging modalities remain investigational in terms of im-
proving clinical outcomes associated with the performance of 
PCI.
3D quantitative coronary angiography and fractional flow 
reserve
Based on a couple of coronary angiograms with different 
angles or rotational coronary angiogram, it is possible to obtain 
3D reconstruction of vessel lumen called 3D QCA with dedicated 
software. 3D reconstruction could generate vessel volume and 
dimensions which are well compared with intracoronary imag-
ing. Tu et al. (46) showed a good correlation between 3D QCA 
(QAngio XA 3D software, Medis Specials BV, Leiden, The Neth-
erlands) and IVUS (r=0.799, p<0.001) or OCT (r=0.897, r<0.001) for 
the assessment of lumen area, with a trend toward larger lumen 
area by IVUS (6.29±2.77 mm2 vs. 5.08±2.34 mm2) or OCT (7.01±3.28 
mm2 vs. 5.93±2.66 mm2). 3D QCA diagnosis performance was com-
pared with FFR in 77 vessels and 68 patients with a cutoff value 
<2.11 mm2; the sensitivity was 83% and the specificity was 56% to 
predict FFR <0.80. 
Quantitative flow reserve and fractional flow reserve
Quantitative flow reserve (QFR) reconstructs anatomical 
models using 3D QCA and subsequently applies fluid dynamic 
equations using the patient-specific hyperemic flow rate derived 
by 3D QCA. TIMI frame count as a boundary condition was com-
pared with FFR in 308 patients, and 332 vessels showed a good 
overall sensitivity of 95% and specificity of 92%. Of note, like FFR, 
QFR cutoff value was <0.80. In this study, for the subgroup with 
FFR between 0.75 and 0.85, a numerical difference between QFR 
and FFR could lead to clinical discordance, QFR still had good 
diagnostic accuracy [86.0% (95% CI: 77.9%-91.9%)] (47). We re-
ported the sensitivity and specificity of previous techniques de-
scribed compared to FFR as the gold standard in the Table 1 and 
Figure 4.
Limitations and impact of risk factors
Little doubt exists concerning the benefit to widely adopt the 
use of FFR for revascularization clinical decision-making. FFR 
demonstrates a continuous link with outcomes when treated 
Figure 4. Sensitivity and specificity (%) of studies comparing the 
diagnostic efficacy of techniques with FFR as gold standard (Table 1)
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with medical therapy. Therefore, lesions with lower FFR values 
receive larger absolute benefits from revascularization (48). Thus, 
FFR links coronary physiology severity to clinical outcome. In sub-
groups of patients who have microvascular disease, the coronary 
flow might be reduced due to microvascular impairment with a 
higher FFR value compared with a subgroup with preserved cor-
onary microcirculation. Thus, clinical outcome should be better 
predicted by evaluations of both macrocirculation and microcir-
culation, which is rarely performed in clinical practice. In a study 
evaluating the diagnosis accuracy of VE and QCA compared with 
FFR according to the type and number of risk factors, the predic-
tive accuracy of VE and QCA was moderate in patients without 
risk factors and weakened as risk factors accumulated. Particu-
larly in patients with diabetes, FFR was significantly higher than 
that in patients without diabetes with comparable stenoses. In 
this subgroup of patients with diabetes, VE and QCA diagnostic 
accuracy to predict FFR result was not different compared with a 
toss coin test (13). Therefore, the more the patients have high car-
diovascular risk, the lesser the angiographic indices are reliable, 
and consequently, the more FFR is needed. Virtual FFR derived 
from computed tomography or angiography is a promising tool to 
predict FFR based on the assumption of preserved flow reserve 
and myocardial mass. In patients with microvascular impairment 
such as diabetes, a high index of microvascular resistance or 
post myocardial infarction diagnosis accuracy might be lower; 
therefore, test results should be taken with cautions (49, 50).
Conclusion
Coronary angiogram evaluation of coronary stenosis is limited 
to assess the ischemic impact on the myocardium. Sophisticated 
technologies based on anatomical description of stenosis than 
on FFR failed to have reliable measurements. The remaining rea-
son is that many other factors beyond coronary stenosis diam-
eter interplay in this anatomical–functional mismatch, which are 
not seen on the coronary angiogram and intracoronary imaging. 
Therefore, the use of FFR should be as extensive as possible to 
assess the functional significance of a coronary stenosis when 
a noninvasive test is not available or to confirm the noninvasive 
test results, if necessary. Future promising techniques virtually 
evaluate FFR from coronary angiogram, which evolve the clas-
sical 2D black and white angiogram to a 3D vessel with a color 
code corresponding to the FFR value. These techniques could 
help to generalize the functional evaluation of coronary stenosis 
in clinical practice.
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